000 02241nam a22003495i 4500
001 75998
003 ES-MaUEC
005 20230207040205.0
007 cr nn 008mamaa
008 130706s2013 xxu| s |||| 0|eng d
020 _a9781461477594
040 _aES-MaUEC
050 4 _aQP355.2
_bB675 2013 EB
100 1 _aBorisova, Tatiana
_984788
_0Local
245 1 0 _aCholesterol and Presynaptic Glutamate Transport in the Brain
_cby Tatiana Borisova
260 _aNew York
_bSpringer International Publishing
_c2013
300 _a1 recurso en línea (XVI, 75 p.) 32 il., 11 il. col.
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 1 _aSpringerBriefs in Neuroscience
_x2191-558X
_v12
520 _aGlutamate is the primary excitatory neurotransmitter in the CNS and disturbances in glutamate transport contribute to a number ofÂ{uE975}rological and neurodegenerative disorders.Â{u0070}propriate levels of cholesterol are very important for the proper functioning of glutamate transport whileÂ{u5BA2}alanced levels ofÂ{u3A2F}lesterol have been implicated in the pathogenesis of disorders such as stroke, ischemia, traumatic brain injury, and neurotoxicity.Â{u2802}Â{u9BA0} the proposed book, the author presents data from the literature and from her own lab to address the extent to and way in which membrane cholesterol modulates presynaptic glutamate transport and whether lowering the level of cholesterol available can offer some neuroprotective benefits.
942 _2lcc
_cLE
988 _aEBOOK, EBSPRINGERrevisado
650 7 _aNeurociencias
_0comprobar BNE20012490612
_2embne
_9158907
830 0 _aSpringerBriefs in Neuroscience
_x2191-558X
_v12
_9133171
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-1-4614-7759-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9781461477594
907 _a.b12816164
_b10-10-17
_c01-10-14
998 _am
_a_alco
_a_vill
_b26-02-17
_cm
_dz
_eo
_feng
_gxxu
_h0
945 _aQP355.2 B675 2013 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11545549
_z06-04-17
999 _c75998
_d75998
_x1